Antares Pharma Inc Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 2 of 2 Posts
Update On Currently Recommended Stocks
Article By: SmithOnStocks Monday, September 25, 2017 4:19 PM EST
In this report I update my objectives and include several buy recommendations in the biotech sphere.
In this article: CYTK, AIS, NWBO, PTLA, RGEN, CYRX, BMY, ALIM, AGEN, EYPT, AMAG, WINT, AMGN, GNE, BIIB
Read
Antares: Pipeline Is Bursting With Late Stage Products (ATRS, $2.77, Buy)
Article By: SmithOnStocks Thursday, March 23, 2017 3:16 PM EST
Antares has an impressive portfolio of seven new products that could lead to explosive growth over the next four years.
In this article: AIS
Read
1 to 2 of 2 Posts